Swallowing the FDA red pill
Earlier this month, the Biden administration bought 10 million courses of Pfizer’s new COVID-19 pill, Paxlovid.
In clinical trials, Paxlovid proved nearly 90% effective at preventing hospitalization and death. The results were so promising, Pfizer ended its trial of the drug early. It would have been unethical to continue denying the antiviral pill to those in the placebo group. The decision to suspend the trial was made “in consultation with the FDA.”
Let’s pause to appreciate the absurdity. Depriving participants in the clinical trial of Paxlovid is considered unethical because it could save their lives. But depriving the thousands of people each day who are contracting COVID-19 of the drug is perfectly fine.